| 今开：1.4 | 昨收：1.41 |
| 最高：1.44 | 最低：1.315 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.6398126E7 |
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-01 03:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006036 Act: 34 Size: 13 KB 网页链接查看全文
Cue Biopharma(CUE)今天 04:05
$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072 Act: 34 Size: 1 MB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028611 Size: 5 KB 网页链接查看全文
$Cue Biopharma, Inc.(CUE)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-30 AccNo: 0001193125-18-143352 Size: 228 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ DEF 14A - Other definitive proxy statements Filed: 2018-04-30 AccNo: 0001193125-18-143127 Size: 498 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2018-03-29 AccNo: 0001144204-18-017986 Size: 88 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-03-29 AccNo: 0001144204-18-017978 Size: 1 MB 网页链接
$Cue Biopharma, Inc.(CUE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000899140-18-000164 Size: 66 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000899140-18-000164 Size: 66 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-01-26 AccNo: 0001144204-18-004077 Size: 16 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Regi...
$Cue Biopharma, Inc.(CUE)$ CORRESP [Cover] - Correspondence Filed: 2017-12-13 AccNo: 0001571049-17-008699 Size: 10 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-01-09 AccNo: 0001174947-18-000012 Size: 31 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ CERT [Paper] - Film#: 171261052 Filed: 2017-12-18 AccNo: 9999999997-17-010648 Size: 85 KB 网页链接